1. Home
  2. TCBK vs MDXG Comparison

TCBK vs MDXG Comparison

Compare TCBK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$46.13

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$4.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
MDXG
Founded
1975
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.0B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
TCBK
MDXG
Price
$46.13
$4.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$53.80
$10.00
AVG Volume (30 Days)
142.0K
780.8K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
3.09%
N/A
EPS Growth
6.94
14.29
EPS
3.70
0.32
Revenue
$53,445,000.00
$418,630,000.00
Revenue This Year
$12.03
N/A
Revenue Next Year
$4.47
$13.14
P/E Ratio
$12.58
$13.03
Revenue Growth
4.12
19.99
52 Week Low
$35.20
$4.12
52 Week High
$53.18
$8.12

Technical Indicators

Market Signals
Indicator
TCBK
MDXG
Relative Strength Index (RSI) 36.07 24.51
Support Level $44.38 N/A
Resistance Level $51.11 $5.38
Average True Range (ATR) 1.17 0.16
MACD -0.14 -0.02
Stochastic Oscillator 18.87 13.29

Price Performance

Historical Comparison
TCBK
MDXG

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: